Company:  CAMBREX CORP (CBM)
Form Type:  10-Q
Filing Date:  11/5/2008 
CIK:  0000820081 
Address:  ONE MEADOWLANDS PLZ 
City, State, Zip:  E RUTHERFORD, New Jersey 07073 
Telephone:  (201) 804-3000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$5.27   		Change: 
0.35 (7.11%)  
Trade Time: 
Feb 09   		Market Cap: 
$154.33M
Description of Business
Cambrex Corporation (the "Company" or "Cambrex"), a Delaware corporation, began business in December 1981. Cambrex is a life sciences company dedicated to growing its portfolio of commercial small molecule therapeutics and providing products and services that accelerate and improve the discovery and commercialization of new therapeutics. The Company primarily supplies its products and services worldwide to pharmaceutical and generic drug companies. Cambrex has three operating segments, which are manufacturing facilities, that have been aggregated as one reportable segment.
Register for a Free Trial and access this filing in:     
  FORM 10-Q
    Part I - FINANCIAL INFORMATION
      ITEM 1. FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II - OTHER INFORMATION
      ITEM 1. LEGAL PROCEEDINGS
      ITEM 1A. RISK FACTORS
      ITEM 6. EXHIBITS
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ...
  EXHIBIT 31.2
    CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ...
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ...
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ...
BROKERAGE PARTNERS
© 1995-2010 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement